Evogene Stock Investor Sentiment

EVGN Stock  USD 0.66  0.01  1.54%   
About 60% of all Evogene's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Evogene suggests that some traders are interested. Evogene's investor sentiment overview provides quick insight into current market opportunities from investing in Evogene. The current market sentiment, together with Evogene's historical and current headlines, can help investors time the market. In addition, many technical investors use Evogene stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Evogene stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Evogene daily returns and investor perception about the current price of Evogene as well as its diversification or hedging effects on your existing portfolios.
  

Evogene Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Evogene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a week ago at news.google.com         
Lavie Bio to Host a Round Table Discussion and is a Sponsor at World Agri-Tech Conference in San Fra...
Google News at Macroaxis
over a week ago at news.google.com         
Evogene Announces Pricing of US8,500,000 Registered Direct Offering - The Globe and Mail
Google News at Macroaxis
over a week ago at news.google.com         
Evogene Could Find a Support Soon, Heres Why You Should Buy the Stock Now - Yahoo Lifestyle Australi...
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Biomica to Present at Digestive Disease Week Conference 2024 Annual Meeting
Yahoo News
over two weeks ago at news.google.com         
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizi...
Google News at Macroaxis
over three weeks ago at benzinga.com         
Fungicides Market Size is projected to reach USD 23,393.85 million by 2031, growing at a CAGR of 4.6...
benzinga news
over three weeks ago at news.google.com         
Is Evogene Ltd Stock About to Get Hot Tuesday - InvestorsObserver
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
Yahoo News
over a month ago at seekingalpha.com         
Evogene gets non-compliance notice from Nasdaq
seekingalpha News
over a month ago at insidermonkey.com         
Evogene Ltd. Q4 2023 Earnings Call Transcript
insidermonkey News
over a month ago at finance.yahoo.com         
Evogene Q4 Earnings Snapshot
Yahoo News
over a month ago at investorplace.com         
EVGN Stock Earnings Evogene Beats EPS, Misses Revenue for Q4 2023
sbwire news
over a month ago at seekingalpha.com         
Evogene GAAP EPS of -0.13 beats by 0.01, revenue of 0.58M misses by 0.31M
seekingalpha News
over a month ago at finance.yahoo.com         
Evogene Reports Q4 Loss, Misses Revenue Estimates
Yahoo News
over a month ago at seekingalpha.com         
Evogene Q4 2023 Earnings Preview
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Evogene that are available to investors today. That information is available publicly through Evogene media outlets and privately through word of mouth or via Evogene internal channels. However, regardless of the origin, that massive amount of Evogene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Evogene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Evogene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Evogene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Evogene alpha.

Evogene Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
02/06/2024
2
Evogene Stock Price Crosses Above 50-Day Moving Average of 0.83 - AmericanBankingNEWS
02/27/2024
3
Casterra signs agreements in Brazil and Africa for castor seed varieties
03/05/2024
4
Evogene Q4 Earnings Snapshot
03/07/2024
5
Evogene Ltd. Q4 2023 Earnings Call Transcript
03/08/2024
6
Is Evogene Ltd Stock About to Get Hot Tuesday - InvestorsObserver
03/26/2024
7
Biomica to Present at Digestive Disease Week Conference 2024 Annual Meeting
04/11/2024
8
Lavie Bio to Host a Round Table Discussion and is a Sponsor at World Agri-Tech Conference in San Francisco - The Globe and Mail
04/15/2024
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:
Check out Evogene Hype Analysis, Evogene Correlation and Evogene Performance.
To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.
Note that the Evogene information on this page should be used as a complementary analysis to other Evogene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Evogene Stock analysis

When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Evogene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.52)
Revenue Per Share
0.123
Quarterly Revenue Growth
(0.12)
Return On Assets
(0.31)
Return On Equity
(0.82)
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.